Why are we working on developing the Antiviral System Virudol? During the coronavirus crisis, people wore face masks everywhere in public to protect themselves from the viral load. This fact gave rise to the idea of developing a new type of virus protection, the antiviral system Virudol®. It consists of the mouth and nose spray Virudol®, whereby this medical product can be administered individually. In addition, it can be combined with an air system called Virudol® Air.
Viral inhibition by Antiviral System Virudol
Viruses in the air are inhibited here in such a way that the possibility of penetrating human cells is reduced. The third component is Virudol® Sup, a dietary supplement that also strengthens the immune system against viral attacks. After Virudol® was primarily developed against corona viruses, it became clear that the mechanism of action, in particular of the oral and nasal spray Virudol®, can also be used to protect against other viruses. It forms a film on the mucous membranes of the mouth and nose, which is structured like a mesh.
Viruses cannot penetrate this, get stuck and are additionally inhibited by substances on it. Virudol® should also protect against other viruses that spread through droplet infections, such as flu viruses, and possibly also against RSV (respiratory syncytial virus), which often causes respiratory diseases in small children. Virudol® contains natural substances from algae and plants that have been known for a very long time and whose tolerability in the concentrations used has been shown several times. Molecular studies have demonstrated the mechanism of action and due to high binding affinities, low concentrations are effective.
In clonclusion
Virudol® presents a completely new natural approach to combating respiratory viruses. MVS Pharma has patented how viruses can be inhibited or blocked at the molecular level before they penetrate human cells. If it is used and understood as simply as washing hands, it can provide simple but effective protection against both self-infection and transmission in private and public spaces when used by everyone present. This is currently an issue in doctor’s offices, hospitals, meeting rooms and public transport during the virus-rich months. Virudol® contains long-known, natural substances that are absolutely well tolerated, even when used regularly. It protects people from infection during the virus season and prevents general spread in critical locations.
You can learn everything about this product on it’s official product page – Oral-nasal spray Virudol®.
Disclaimer:
As a service to our readers, MVS Pharma GmbH publishing provides access to our library of archived content — in our blog. Please note the date of the last review or update on all articles. No content on this site should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
MVS Pharma GmbH will soon be launching an omega-3 dietary supplement onto the European market that has been developed for the highest quality standards in terms of oxidation avoidance and therefore greatest bioavailability. In addition, in vitro studies are currently underway at the University of Ulm, in which Professor Dr. Rüdiger Groß tested a patented mouth and nose spray (Virudol) that can eliminate various flu viruses based on natural substances. In addition, MVS has a wholesale license and has specialized in sourcing much-needed medicines such as Amoxicillin, Salbutamol, etc. from India through its local branch with a focus on local quality and safety testing, compliance with international GMP regulations and the highest quality level of user security (examples of local language brochures, identical units of measurement, batch control and full tracking, etc.).
